共 50 条
- [34] National Care Guideline "Therapy of Type-2-Diabetes" published [J]. ZEITSCHRIFT FUR EVIDENZ FORTBILDUNG UND QUALITAET IM GESUNDHEITSWESEN, 2013, 107 (08): : 515 - 515
- [35] Type-2-Diabetes Therapy with selective SGLT-2-Inhibitor [J]. DIABETES STOFFWECHSEL UND HERZ, 2013, 22 (06):
- [36] Injection Therapy for Type-2-Diabetes New Data on Dulaglutide: Diabetes Therapy even easier [J]. DIABETES STOFFWECHSEL UND HERZ, 2020, 29 (01): : 57 - 58
- [37] Association between BMI and Mortality in Patients with Type-2-Diabetes [J]. DIABETOLOGE, 2013, 9 (04): : 310 - 311
- [38] Comparison of Insulin Therapy with Insulin Glargin and Insulin Degludec/Liraglutid in Patients with Type-2-diabetes [J]. DIABETOLOGE, 2016, 12 (03): : 201 - 202
- [39] Pioglitazone in renal dialysis patients with type-2-diabetes mellitus [J]. DIABETES, 2005, 54 : A508 - A508
- [40] Amyloid Formation in Type-2-Diabetes [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (08) : 442 - 442